Hsin-Hua Hsieh , Pei-An Chu , Yu-Hsin Lin , Yu-Chieh Jill Kao , Yi-Hsiu Chung , Shih-Ting Hsu , Jia-Min Mo , Chun-Yi Wu , Shin-Lei Peng
{"title":"Imaging diabetic cardiomyopathy in a type 1 diabetic rat model using 18F-FEPPA PET","authors":"Hsin-Hua Hsieh , Pei-An Chu , Yu-Hsin Lin , Yu-Chieh Jill Kao , Yi-Hsiu Chung , Shih-Ting Hsu , Jia-Min Mo , Chun-Yi Wu , Shin-Lei Peng","doi":"10.1016/j.nucmedbio.2024.108878","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Diabetic patients often experience chronic inflammation and fibrosis in their cardiac tissues, highlighting the pressing need for the development of sensitive diagnostic methods for longitudinal assessment of diabetic cardiomyopathy. This study aims to evaluate the significance of an inflammatory marker known as translocator protein (TSPO) in a positron emission tomography (PET) protocol for longitudinally monitoring cardiac dysfunction in a diabetic animal model. Additionally, we compared the commonly used radiotracer, <sup>18</sup>F-fluoro-2-deoxy-<span>d</span>-glucose (<sup>18</sup>F-FDG).</p></div><div><h3>Methods</h3><p>Fourteen 7-week-old female Sprague-Dawley rats were used in this study. Longitudinal PET experiments were conducted using <sup>18</sup>F-<em>N</em>-2-(2-fluoroethoxy)benzyl)-<em>N</em>-(4-phenoxypyridin-3-yl)acetamide (<sup>18</sup>F-FEPPA) (<em>n</em> = 3), the TSPO radiotracer, and <sup>18</sup>F-FDG (n = 3), both before and after the onset of diabetes. Histological and immunohistochemical staining assays were also conducted in both the control (<em>n</em> = 4) and diabetes (n = 4) groups.</p></div><div><h3>Results</h3><p>Results indicated a significant increase in cardiac tissue uptake of <sup>18</sup>F-FEPPA after the onset of diabetes (<em>P</em> < 0.05), aligning with elevated TSPO levels observed in diabetic animals according to histological data. Conversely, the uptake of <sup>18</sup>F-FDG in cardiac tissue significantly decreased after the onset of diabetes (P < 0.05).</p></div><div><h3>Conclusion</h3><p>These findings suggest that <sup>18</sup>F-FEPPA can function as a sensitive probe for detecting chronic inflammation and fibrosis in the cardiac tissues of diabetic animals.</p></div>","PeriodicalId":19363,"journal":{"name":"Nuclear medicine and biology","volume":"128 ","pages":"Article 108878"},"PeriodicalIF":3.6000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0969805124000040/pdfft?md5=dc8dde21cd5f9959b65d3c8fb5d5d437&pid=1-s2.0-S0969805124000040-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nuclear medicine and biology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0969805124000040","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
Diabetic patients often experience chronic inflammation and fibrosis in their cardiac tissues, highlighting the pressing need for the development of sensitive diagnostic methods for longitudinal assessment of diabetic cardiomyopathy. This study aims to evaluate the significance of an inflammatory marker known as translocator protein (TSPO) in a positron emission tomography (PET) protocol for longitudinally monitoring cardiac dysfunction in a diabetic animal model. Additionally, we compared the commonly used radiotracer, 18F-fluoro-2-deoxy-d-glucose (18F-FDG).
Methods
Fourteen 7-week-old female Sprague-Dawley rats were used in this study. Longitudinal PET experiments were conducted using 18F-N-2-(2-fluoroethoxy)benzyl)-N-(4-phenoxypyridin-3-yl)acetamide (18F-FEPPA) (n = 3), the TSPO radiotracer, and 18F-FDG (n = 3), both before and after the onset of diabetes. Histological and immunohistochemical staining assays were also conducted in both the control (n = 4) and diabetes (n = 4) groups.
Results
Results indicated a significant increase in cardiac tissue uptake of 18F-FEPPA after the onset of diabetes (P < 0.05), aligning with elevated TSPO levels observed in diabetic animals according to histological data. Conversely, the uptake of 18F-FDG in cardiac tissue significantly decreased after the onset of diabetes (P < 0.05).
Conclusion
These findings suggest that 18F-FEPPA can function as a sensitive probe for detecting chronic inflammation and fibrosis in the cardiac tissues of diabetic animals.
期刊介绍:
Nuclear Medicine and Biology publishes original research addressing all aspects of radiopharmaceutical science: synthesis, in vitro and ex vivo studies, in vivo biodistribution by dissection or imaging, radiopharmacology, radiopharmacy, and translational clinical studies of new targeted radiotracers. The importance of the target to an unmet clinical need should be the first consideration. If the synthesis of a new radiopharmaceutical is submitted without in vitro or in vivo data, then the uniqueness of the chemistry must be emphasized.
These multidisciplinary studies should validate the mechanism of localization whether the probe is based on binding to a receptor, enzyme, tumor antigen, or another well-defined target. The studies should be aimed at evaluating how the chemical and radiopharmaceutical properties affect pharmacokinetics, pharmacodynamics, or therapeutic efficacy. Ideally, the study would address the sensitivity of the probe to changes in disease or treatment, although studies validating mechanism alone are acceptable. Radiopharmacy practice, addressing the issues of preparation, automation, quality control, dispensing, and regulations applicable to qualification and administration of radiopharmaceuticals to humans, is an important aspect of the developmental process, but only if the study has a significant impact on the field.
Contributions on the subject of therapeutic radiopharmaceuticals also are appropriate provided that the specificity of labeled compound localization and therapeutic effect have been addressed.